CKII Site in Epstein-Barr Virus Nuclear Protein 2 Controls Binding to hSNF5/Ini1 and Is Important for Growth Transformation

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Virology

• Publication date

  2004-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.78.11.6067-6072.2004PMID 15141006PMCID PMC415811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in understanding chromatin remodeling by Swi/Snf complexes.

  2003cited by this paper
• Epstein-Barr Virus Nuclear Antigen 2 Binds via Its Methylated Arginine-Glycine Repeat to the Survival Motor Neuron Protein

  2003cited by this paper
• One‐thousand‐and‐one substrates of protein kinase CK2?

  2003cited by this paper
• The Conserved Mynd Domain of BS69 Binds Cellular and Oncoviral Proteins through a Common PXLXP Motif*

  2002cited by this paper
• A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle

  2002cited by this paper
• Epstein–Barr virus EBNA2 blocks Nur77- mediated apoptosis

  2002cited by this paper
• Expression of Transcription Factor AML-2 (RUNX3, CBFα-3) Is Induced by Epstein-Barr Virus EBNA-2 and Correlates with the B-Cell Activation Phenotype

  2002cited by this paper
• Cooperation between complexes that regulate chromatin structure and transcription.

  2002cited by this paper
• Notch1IC Partially Replaces EBNA2 Function in B Cells Immortalized by Epstein-Barr Virus

  2001influential reference
• Promoter-Specific Targeting of Human SWI-SNF Complex by Epstein-Barr Virus Nuclear Protein 2

  2000cited by this paper
• Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.

  2000cited by this paper
• A Role for SKIP in EBNA2 Activation of CBF1-Repressed Promoters

  2000cited by this paper
• Mechanisms for ATP-dependent chromatin remodelling.

  2000cited by this paper
• The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression

  2000cited by this paper
• A C/EBPβ Isoform Recruits the SWI/SNF Complex to Activate Myeloid Genes

  1999cited by this paper
• Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.

  1999cited by this paper
• Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

  1999cited by this paper
• Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors.

  1999cited by this paper
• A C/EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes.

  1999cited by this paper
• The Proto-Oncogene c-myc Is a Direct Target Gene of Epstein-Barr Virus Nuclear Antigen 2

  1999cited by this paper
• Characterization of DP103, a Novel DEAD Box Protein That Binds to the Epstein-Barr Virus Nuclear Proteins EBNA2 and EBNA3C*

  1999cited by this paper
• A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro.

  1998cited by this paper
• An ATF/CRE Element Mediates both EBNA2-Dependent and EBNA2-Independent Activation of the Epstein-Barr Virus LMP1 Gene Promoter

  1998cited by this paper
• Chromatin remodeling machines: similar motors, ulterior motives.

  1998cited by this paper
• Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

  1998cited by this paper
• Three-dimensional structure of the tyrosine kinase c-Src

  1997cited by this paper
• Regulation of Epstein-Barr virus latency by latent membrane protein 2.

  1996cited by this paper
• Epstein-Barr virus nuclear protein 2 (EBNA2) binds to a component of the human SNF-SWI complex, hSNF5/Ini1

  1996cited by this paper
• Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.

  1996cited by this paper
• Purification and biochemical heterogeneity of the mammalian SWI‐SNF complex.

  1996cited by this paper
• The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2.

  1995cited by this paper
• PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.

  1995cited by this paper
• Rat monoclonal antibodies differentiating between the Epstein-Barr virus nuclear antigens 2A (EBNA2A) and 2B (EBNA2B).

  1995cited by this paper
• The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein

  1995cited by this paper
• B‐cell proliferation and induction of early G1‐regulating proteins by Epstein‐Barr virus mutants conditional for EBNA2.

  1995cited by this paper
• Expression of Epstein‐Barr virus nuclear antigen‐2 (EBNA2) induces CD21/CR2 on B and T cell lines and shedding of soluble CD21

  1995cited by this paper
• Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1

  1995cited by this paper
• Epstein‐Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP‐J kappa, the homologue of Drosophila Suppressor of Hairless.

  1994cited by this paper
• Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes

  1994cited by this paper
• The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.

  1994cited by this paper
• Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

  1994cited by this paper
• The Spi‐1/PU.1 and Spi‐B ets family transcription factors and the recombination signal binding protein RBP‐J kappa interact with an Epstein‐Barr virus nuclear antigen 2 responsive cis‐element.

  1994cited by this paper
• Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease.

  1994cited by this paper
• Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.

  1994cited by this paper
• Lymphotoxin is an autocrine growth factor for Epstein-Barr virus- infected B cell lines

  1993cited by this paper
• Epstein‐barr virus (EBV) nuclear‐antigen‐2‐induced up‐regulation of cd21 and cd23 molecules is dependent on a permissive cellular context

  1993cited by this paper
• Phosphorylation of the Epstein-Barr virus nuclear antigen 2.

  1992influential reference
• Biochemical characterization of Epstein-Barr virus nuclear antigen 2A

  1991cited by this paper
• Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene

  1991cited by this paper
• EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus

  1991cited by this paper
• The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization

  1990cited by this paper
• Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1

  1990cited by this paper
• Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein‐Barr virus (EBV)

  1990cited by this paper
• Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23

  1990cited by this paper
• Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

  1989cited by this paper
• Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes

  1989cited by this paper
• A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

  1988cited by this paper
• Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells

  1987cited by this paper
• Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

  1987cited by this paper
• U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.

  1984cited by this paper

• Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genome

  2024cites this paper
• Functional diversity: update of the posttranslational modification of Epstein–Barr virus coding proteins

  2022cites this paper
• PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice

  2021cites this paper
• Inhibition of PLK1-dependent EBNA2 phosphorylation promotes lymphomagenesis in EBV-infected mice

  2021cites this paper
• Herpesvirus Epigenetic Reprogramming and Oncogenesis.

  2020cites this paper
• EBNA2 and Its Coactivator EBNA-LP.

  2015cites this paper
• Epstein-Barr virus genetic variants are associated with multiple sclerosis

  2015cites this paper
• Wongabel Rhabdovirus Accessory Protein U3 Targets the SWI/SNF Chromatin Remodeling Complex

  2014cites this paper
• Wongabel rhabdovirus accessory protein U 3 targets the SWI / SNF chromatin 3 remodelling complex 4 5

  2014cites this paper
• Caractérisation structurale et fonctionnelle des interactions impliquant TFIIH et les domaines de transactivation viraux

  2014cites this paper
• NMR and Fluorescence Studies of DNA Binding Domain of INI1/hSNF5

  2014cites this paper
• Mechanism of superior B cell immortalisation activity of type 1 Epstein-Barr virus

  2014cites this paper
• Epstein Barr virus EBNA2 : interactions of intrinsically disordered proteins with host cell factors.

  2013cites this paper
• SWI/SNF Chromatin-remodeling Factors: Multiscale Analyses and Diverse Functions*

  2012cites this paper
• Lymphocryptoviruses: EBV and Its Role in Human Cancer

  2012cites this paper
• C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7

  2011cites this paper
• Collection and Motif-Based Prediction of Phosphorylation Sites in Human Viruses

  2010cites this paper
• The role of INI1/hSNF5 in gene regulation and cancer.

  2009cites this paper
• Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.

  2009cites this paper
• Regulation of the STAT1 by the Epstein-Barr virus.

  2007cites this paper
• Heterogeneity of CK2 phosphorylation sites in the NS5A protein of different hepatitis C virus genotypes.

  2007cites this paper
• cdc2/Cyclin B1-Dependent Phosphorylation of EBNA2 at Ser243 Regulates Its Function in Mitosis

  2006cites this paper
• The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription

  2006cites this paper
• The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter

  2005cites this paper
• Hyperphosphorylation of EBNA2 by Epstein-Barr Virus Protein Kinase Suppresses Transactivation of the LMP1 Promoter

  2005cites this paper